JPRN-jRCT2031220658进行中（未招募）1 期
A Single-Ascending Dose Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-2060 in Healthy Japanese Participants
Tanaka Yoshiyuki0 个研究点目标入组 48 人开始时间: 2023年2月23日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 50age old（—）
- 性别
- All
入选标准
- •Healthy male or female aged 18 to 50 years old with BMI 18 to 32 kg/m2
排除标准
- •Has a history of clinically significant abnormalities or diseases
研究者
相似试验
招募中
1 期
A phase I study of epinephrine sublingual tablet in healthy subjectsCTRI/2020/09/027808Belcher Pharmaceuticals
已完成
不适用
An open-label, single ascending dose study to evaluate the safety and pharmacokinetics of a tablet formulation of CG-549 in healthy subjectsbacterial infections10004018NL-OMON48209CrystalGenomics, Inc24
已完成
1 期
Single Administration Study of Sotatercept (MK-7962) in Healthy Japanese ParticipantsPulmonary arterial hypertensionJPRN-jRCT2051220078Yoshiyuki Tanaka26
招募中
1 期
Single Administration study of Bomedemstat (MK-3543) in Healthy JapaneseEssential thrombocythaemiaJPRN-jRCT2071230096Tanaka Yoshiyuki45
招募中
1 期
A Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BW-20507 in Healthy SubjectsChronic Hepatitis B Virus (HBV) InfectionInfection - Studies of infection and infectious agentsOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12623000709640Argo Biopharma Australia Pty Ltd32